Literature DB >> 15527627

Bariatric surgery worldwide 2003.

Henry Buchwald1, Stanley E Williams.   

Abstract

BACKGROUND: There is a world epidemic of overweight, obesity, and morbid obesity, encompassing 1.7 billion people. Bariatric surgery today is the only effective therapy for morbid obesity.
METHODS: E-mail requests for information were sent to the presidents of the national societies of the 31 International Federation for the Surgery of Obesity (IFSO) nations, or national groupings, plus Sweden. Responses were tabulated; calculation of relative prevalence of specific procedures was done by weighted averages.
RESULTS: Responders were 26 of 32 (81%) for the general questions and 24 of 32 (75%) for the question on specific operative percentages. In the year 2002-2003, 146,301 bariatric surgery operations were performed by 2,839 bariatric surgeons; 103,000 of these operations were performed in USA/Canada by 850 surgeons. The earliest start date for bariatric surgery was 1953 in the USA; IFSO was founded in 1995. In the year 2002-2003, 37.15% of operations were open; 62.85% laparoscopic. The 6 most popular procedures by weighted averages were: laparoscopic gastric bypass, 25.67%; laparoscopic adjustable gastric banding, 24.14%; open gastric bypass, 23.07%; laparoscopic long-limb gastric bypass, 8.9%; open long-limb gastric bypass, 7.45%; and open vertical banded gastroplasty, 4.25%. Pooling open and laparoscopic procedures, relative percentages were: gastric bypass, 65.11%; gastric banding, 24.41%; vertical banded gastroplasty, 5.43%; and biliopancreatic diversion/duodenal switch, 4.85%. Categorizing into restrictive/malabsorptive, purely restrictive, and primarily malabsorptive, the relative distribution of procedures was 65.11%, 29.84%, and 4.85%, respectively. The number of countries performing gastric banding was 23 (95%), gastric bypass 21 (88%), vertical banded gastroplasty 19 (79%), and biliopancreatic diversion/duodenal switch 16 (67%). Purely restrictive procedures were performed in 24 (100%) of the countries, restrictive/malabsorptive in 21 (88%), and primarily malabsorptive in 18 (75%).
CONCLUSIONS: Bariatric surgery is expanding exponentially to meet the global epidemic of morbid obesity. Operative procedures in bariatric surgery are in flux and specific geographic trends and shifts are evident. Yet, of the patients qualifying for surgery, only about 1% are receiving this therapy--the only effective treatment currently available.

Entities:  

Mesh:

Year:  2004        PMID: 15527627     DOI: 10.1381/0960892042387057

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  203 in total

Review 1.  The neurohormonal regulation of energy intake in relation to bariatric surgery for obesity.

Authors:  Christopher N Ochner; Charlisa Gibson; Susan Carnell; Carl Dambkowski; Allan Geliebter
Journal:  Physiol Behav       Date:  2010-05-08

2.  Predictors of Remission of T2DM and Metabolic Effects after Laparoscopic Roux-en-y Gastric Bypass in Obese Indian Diabetics-a 5-Year Study.

Authors:  Aparna Govil Bhasker; Carlyne Remedios; Payal Batra; Amit Sood; Shehla Shaikh; Muffazal Lakdawala
Journal:  Obes Surg       Date:  2015-07       Impact factor: 4.129

3.  Technique evolution, learning curve, and outcomes of 200 robot-assisted gastric bypass procedures: a 5-year experience.

Authors:  Vivek Bindal; Raquel Gonzalez-Heredia; Mario Masrur; Enrique F Elli
Journal:  Obes Surg       Date:  2015-06       Impact factor: 4.129

Review 4.  Trends in oral drug bioavailability following bariatric surgery: examining the variable extent of impact on exposure of different drug classes.

Authors:  Adam S Darwich; Kathryn Henderson; Angela Burgin; Nicola Ward; Janet Whittam; Basil J Ammori; Darren M Ashcroft; Amin Rostami-Hodjegan
Journal:  Br J Clin Pharmacol       Date:  2012-11       Impact factor: 4.335

5.  Long-term results and complications following adjustable gastric banding.

Authors:  Monika Lanthaler; Franz Aigner; Johann Kinzl; Michael Sieb; Ferguel Cakar-Beck; Hermann Nehoda
Journal:  Obes Surg       Date:  2010-08       Impact factor: 4.129

6.  Smaller staple height for circular stapled gastrojejunostomy in laparoscopic gastric bypass: early results in 1,074 morbidly obese patients.

Authors:  Nasser Sakran; Ahmad Assalia; Ahud Sternberg; Yoram Kluger; Anton Troitsa; Eran Brauner; Sebastiaan Van Cauwenberge; Marieke De Visschere; Bruno Dillemans
Journal:  Obes Surg       Date:  2011-02       Impact factor: 4.129

7.  Erosive esophagitis after bariatric surgery: banded vertical gastrectomy versus banded Roux-en-Y gastric bypass.

Authors:  Gustavo Peixoto Soares Miguel; João Luiz Moreira Coutinho Azevedo; Paulo Henrique Oliveira de Souza; João de Siqueira Neto; Felipe Mustafa; Evelyn Saiter Zambrana; Perseu Seixas de Carvalho
Journal:  Obes Surg       Date:  2011-02       Impact factor: 4.129

8.  Relation of fasting plasma peptide YY to glucose metabolism and cardiovascular risk factors after restrictive bariatric surgery.

Authors:  Ursula Hanusch-Enserer; Mohammed A Ghatei; Edmund Cauza; Steven R Bloom; Rudolf Prager; Michael Roden
Journal:  Wien Klin Wochenschr       Date:  2007       Impact factor: 1.704

9.  Effect of gastric bypass combined with ileal transportation on type 2 diabetes mellitus.

Authors:  Zhaoxia Gao; Bin Wang; Xiaojun Gong; Chun Yao; Defa Ren; Liwei Shao; Yan Pang; Jinxiu Liu
Journal:  Exp Ther Med       Date:  2018-03-06       Impact factor: 2.447

Review 10.  Initial experience with laparoscopic sleeve gastrectomy by a novice bariatric team in an established bariatric center--a review of literature and initial results.

Authors:  Ashish Dey; Tarun Mittal; Vinod K Malik
Journal:  Obes Surg       Date:  2013-04       Impact factor: 4.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.